Gene mutations in Cushing's disease (Review)
- Authors:
- Qi Xiong
- Wei Ge
-
Affiliations: National Key Laboratory of Medical Molecular Biology and Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing 100005, P.R. China - Published online on: July 29, 2016 https://doi.org/10.3892/br.2016.729
- Pages: 277-282
This article is mentioned in:
Abstract
|
Syro LV, Rotondo F, Ramirez A, Di Ieva A, Sav MA, Restrepo LM, Serna CA and Kovacs K: Progress in the diagnosis and classification of pituitary adenomas. Front Endocrinol (Lausanne). 6:972015.PubMed/NCBI | |
|
Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism) 1932. Obes Res. 2:486–508. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Herman V, Fagin J, Gonsky R, Kovacs K and Melmed S: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 71:1427–1433. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Daly AF and Beckers A: Update on the treatment of pituitary adenomas: Familial and genetic considerations. Acta Clin Belg. 63:418–424. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Stratakis CA, Tichomirowa MA, Boikos S, Azevedo MF, Lodish M, Martari M, Verma S, Daly AF, Raygada M, Keil MF, et al: The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet. 78:457–463. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lecoq AL, Kamenický P, Guiochon-Mantel A and Chanson P: Genetic mutations in sporadic pituitary adenomas - what to screen for? Nat Rev Endocrinol. 11:43–54. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, et al: Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab. 91:3316–3323. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Asa SL and Ezzat S: The pathogenesis of pituitary tumors. Annu Rev Pathol. 4:97–126. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Mäkinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T, et al: Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc Natl Acad Sci USA. 104:4101–4105. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, Haddad BR, Hughes MR and Chrousos GP: Cushing's disease preceded by generalized glucocorticoid resistance: Clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians. 108:296–307. 1996.PubMed/NCBI | |
|
Perez-Rivas LG and Reincke M: Genetics of Cushing's disease: An update. J Endocrinol Invest. 39:29–35. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, Harding B, Besser GM, Edwards CR, Monson JP, et al: Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet. 62:232–244. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Wautot V, Vercherat C, Lespinasse J, Chambe B, Lenoir GM, Zhang CX, Porchet N, Cordier M, Béroud C and Calender A: Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: Search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mutat. 20:35–47. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Burgess JR, Greenaway TM and Shepherd JJ: Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med. 243:465–470. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Matsuzaki LN, Canto-Costa MH and Hauache OM: Cushing's disease as the first clinical manifestation of multiple endocrine neoplasia type 1 (MEN1) associated with an R460X mutation of the MEN1 gene. Clin Endocrinol (Oxf). 60:142–143. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lamberts SW: Glucocorticoid receptors and Cushing's disease. Mol Cell Endocrinol. 197:69–72. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, et al: Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 312:1228–1230. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Occhi G, Jaffrain-Rea ML, Trivellin G, Albiger N, Ceccato F, De Menis E, Angelini M, Ferasin S, Beckers A, Mantero F, et al: The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect? J Endocrinol Invest. 33:800–805. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, Chapple JP, Trivellin G, Gueorguiev M, Guegan K, et al: International FIPA Consortium: Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat. 31:950–960. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, et al: The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab. 93:2390–2401. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature. 351:453–456. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science. 253:49–53. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Oliveira MC, Marroni CP, Pizarro CB, Pereira-Lima JF, Barbosa-Coutinho LM and Ferreira NP: Expression of p53 protein in pituitary adenomas. Braz J Med Biol Res. 35:561–565. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Sumi T, Stefaneanu L, Kovacs K, Asa SL and Rindi G: Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr Pathol. 4:95–99. 1993. View Article : Google Scholar | |
|
Gandour-Edwards R, Kapadia SB, Janecka IP, Martinez AJ and Barnes L: Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod Pathol. 8:160–164. 1995.PubMed/NCBI | |
|
Lübke D, Saeger W and Lüdecke DK: Proliferation markers and EGF in ACTH-secreting adenomas and carcinomas of the pituitary. Endocr Pathol. 6:45–55. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW and Clayton RN: p53 Protein accumulates in Cushings adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab. 79:1513–1516. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Copelli SB, Loza Coll MA and Bruno OD: Absence of mutations in the p53 tumor suppressor gene in non-invasive Cushing adenomas. Medicina (B Aires). 59:459–462. 1999.PubMed/NCBI | |
|
Levy A, Hall L, Yeudall WA and Lightman SL: p53 gene mutations in pituitary adenomas: Rare events. Clin Endocrinol (Oxf). 41:809–814. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Herman V, Drazin NZ, Gonsky R and Melmed S: Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab. 77:50–55. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Kawashima ST, Usui T, Sano T, Iogawa H, Hagiwara H, Tamanaha T, Tagami T, Naruse M, Hojo M, Takahashi JA, et al: P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease. Clin Endocrinol (Oxf). 70:656–657. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Reutens AT, Achermann JC, Ito M, Ito M, Gu WX, Habiby RL, Donohoue PA, Pang S, Hindmarsh PC and Jameson JL: Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J Clin Endocrinol Metab. 84:504–511. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD and Ingraham HA: Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 93:445–454. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Merke DP, Tajima T, Baron J and Cutler GB Jr: Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N Engl J Med. 340:1248–1252. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Wu CM, Zhang HB, Zhou Q, Wan L, Jin J, Ni L, Pan YJ, Wu XY and Ruan LY: Two novel DAX1 gene mutations in Chinese patients with X-linked adrenal hypoplasia congenita: Clinical, hormonal and genetic analysis. J Endocrinol Invest. 34:e235–e239. 2011.PubMed/NCBI | |
|
Suzuki M, Egashira N, Kajiya H, Minematsu T, Takekoshi S, Tahara S, Sanno N, Teramoto A and Osamura RY: ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells. Endocr Pathol. 19:17–26. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
De Menis E, Roncaroli F, Calvari V, Chiarini V, Pauletto P, Camerino G and Cremonini N: Corticotroph adenoma of the pituitary in a patient with X-linked adrenal hypoplasia congenita due to a novel mutation of the DAX-1 gene. Eur J Endocrinol. 153:211–215. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, et al: Mutations in the deubiquitinase gene USP8 cause Cushing's disease. Nat Genet. 47:31–38. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Perez-Rivas LG, Theodoropoulou M, Ferraù F, Nusser C, Kawaguchi K, Stratakis CA, Faucz FR, Wildemberg LE, Assié G, Beschorner R, et al: The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease. J Clin Endocrinol Metab. 100:E997–E1004. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ma ZY, Song ZJ, Chen JH, Wang YF, Li SQ, Zhou LF, Mao Y, Li YM, Hu RG, Zhang ZY, et al: Recurrent gain-of-function USP8 mutations in Cushing's disease. Cell Res. 25:306–317. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bernstein E, Caudy AA, Hammond SM and Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 409:363–366. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G and Mello CC: Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell. 106:23–34. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW and Dacic S: Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res. 67:2345–2350. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski JA, Wikenheiser-Brokamp KA, Suarez BK, Whelan AJ, et al: DICER1 mutations in familial pleuropulmonary blastoma. Science. 325:9652009. View Article : Google Scholar : PubMed/NCBI | |
|
Doros LA, Rossi CT, Yang J, Field A, Williams GM, Messinger Y, Cajaiba MM, Perlman EJ, A Schultz K, Cathro HP, et al: DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol. 27:1267–1280. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wildi-Runge S, Bahubeshi A, Carret A, Crevier L, Robitaille Y, Kovacs K, Horvath E, Scheithauer BW, Foulkes WD and Deal C: New phenotype in the familial DICER1 tumor syndrome: Pituitary blastoma presenting at age 9 months. Endocr Rev. 32:P1–P777, (Abstract). 2011. | |
|
Sahakitrungruang T, Srichomthong C, Pornkunwilai S, Amornfa J, Shuangshoti S, Kulawonganunchai S, Suphapeetiporn K and Shotelersuk V: Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease. J Clin Endocrinol Metab. 99:E1487–E1492. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tajima T, Ma XM, Bornstein SR and Aguilera G: Prenatal dexamethasone treatment does not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21-hydroxylase deficient mice. Endocrinology. 140:3354–3362. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Haase M, Schott M, Kaminsky E, Lüdecke DK, Saeger W, Fritzen R, Schinner S, Scherbaum WA and Willenberg HS: Cushing's disease in a patient with steroid 21-hydroxylase deficiency. Endocr J. 58:699–706. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Boronat M, Carrillo A, Ojeda A, Estrada J, Ezquieta B, Marín F and Nóvoa FJ: Clinical manifestations and hormonal profile of two women with Cushing's disease and mild deficiency of 21-hydroxylase. J Endocrinol Invest. 27:583–590. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kozasa T, Itoh H, Tsukamoto T and Kaziro Y: Isolation and characterization of the human Gs alpha gene. Proc Natl Acad Sci USA. 85:2081–2085. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Aldred MA and Trembath RC: Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat. 16:183–189. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G, Smallwood PM and Levine MA: Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 322:1412–1419. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Williamson EA, Ince PG, Harrison D, Kendall-Taylor P and Harris PE: G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest. 25:128–131. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Riminucci M, Collins MT, Lala R, Corsi A, Matarazzo P, Gehron Robey P and Bianco P: An R201H activating mutation of the GNAS1 (Gsalpha) gene in a corticotroph pituitary adenoma. Mol Pathol. 55:58–60. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Chesnokova V, Auernhammer CJ and Melmed S: Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology. 139:2209–2216. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Yano H, Readhead C, Nakashima M, Ren SG and Melmed S: Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: Neuro-immune-endocrine modulation of pituitary development. Mol Endocrinol. 12:1708–1720. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Mathieu ME, Saucourt C, Mournetas V, Gauthereau X, Thézé N, Praloran V, Thiébaud P and Bœuf H: LIF-dependent signaling: New pieces in the Lego. Stem Cell Rev. 8:1–15. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Heutling D, Dieterich KD, Buchfelder M and Lehnert H: Mutation analysis of leukemia inhibitory factor-receptor (LIF-R) in ACTH-secreting pituitary adenomas. Exp Clin Endocrinol Diabetes. 112:458–461. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Roussel-Gervais A, Bilodeau S, Vallette S, Berthelet F, Lacroix A, Figarella-Branger D, Brue T and Drouin J: Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis. Mol Endocrinol. 24:1835–1845. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liu NA, Jiang H, Ben-Shlomo A, Wawrowsky K, Fan XM, Lin S and Melmed S: Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. Proc Natl Acad Sci USA. 108:8414–8419. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Mäkinen MJ, Tuppurainen K, Paschke R, et al: Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab. 92:3321–3325. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Dahia PL, Aguiar RC, Honegger J, Fahlbush R, Jordan S, Lowe DG, Lu X, Clayton RN, Besser GM and Grossman AB: Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Oncogene. 16:69–76. 1998. View Article : Google Scholar : PubMed/NCBI |
